infiltrating bladder urothelial carcinoma
Showing 1 - 9 of 9
Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, Bladder Mixed Adenocarcinoma Trial in Puerto Rico, United States
Recruiting
- Bladder Adenocarcinoma
- +45 more
- Cabozantinib S-malate
- +2 more
-
Birmingham, Alabama
- +563 more
Aug 24, 2022
Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Stage III Bladder Urothelial Carcinoma Trial
Recruiting
- Infiltrating Bladder Urothelial Carcinoma
- +2 more
- Gemcitabine Hydrochloride
- +5 more
-
Fairbanks, Alaska
- +389 more
Aug 2, 2022
Infiltrating Bladder Urothelial Carcinoma Trial in France (Durvalumab, Tremelimumab, MVAC Protocol)
Recruiting
- Infiltrating Bladder Urothelial Carcinoma
- Durvalumab
- +2 more
-
Paris, Ile De France, France
- +14 more
Apr 21, 2022
Infiltrating Bladder Urothelial Carcinoma Trial in Montpellier (Radiation + cisplatin, Radiation + cisplatin + gemcitabine)
Active, not recruiting
- Infiltrating Bladder Urothelial Carcinoma
- Radiation + cisplatin
- Radiation + cisplatin + gemcitabine
-
Montpellier, FranceCRLC Val d'Aurelle-Paul Lamarque
Dec 20, 2021
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021
Infiltrating Bladder Urothelial Carcinoma Trial in Bristol (Cabazitaxel + Cisplatin chemo)
Active, not recruiting
- Infiltrating Bladder Urothelial Carcinoma
- Cabazitaxel + Cisplatin chemotherapy
-
Bristol, United KingdomBristol Haematology + Oncology Centre, Horfield Road
Nov 11, 2020
Infiltrating Bladder Urothelial Carcinoma Trial in Los Angeles (Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Infiltrating Bladder Urothelial Carcinoma
- Quality-of-Life Assessment
- Questionnaire Administration
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Transitional Cell Carcinoma Trial (procedure,
Withdrawn
- Infiltrating Bladder Urothelial Carcinoma
- +2 more
- Biopsy
- +4 more
- (no location specified)
Dec 28, 2017
Infiltrating Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma, Stage III Bladder Urothelial Carcinoma Trial
Withdrawn
- Infiltrating Bladder Urothelial Carcinoma
- +3 more
- Cisplatin
- +3 more
-
Rochester, MinnesotaMayo Clinic
Nov 14, 2017